Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended		166 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013
Operating expenses:
Research and development	$ 55,780	$ 758,250	$ 58,480	$ 765,400	$ 8,934,957
General and administrative	302,630	365,986	564,596	639,643	16,564,142
Total operating expense	358,410	1,124,236	623,076	1,405,043	25,499,099
Operating loss	(358,410)	(1,124,236)	(623,076)	(1,405,043)	(25,499,099)
Incentive for early warrant exericise	0	0	0	0	(1,999,622)
Incentive for early warrant exercise-related parties	0	0	0	0	(727,481)
Interest income	0	0	0	0	23,867
Interest expense-other	(68,741)	(32,041)	(119,044)	(64,953)	(5,830,865)
Interest expense-related parties	(12,469)	(19,529)	(37,133)	(34,002)	(2,444,074)
Debt extinguishment expense	(64,161)	(70,008)	(115,796)	(75,940)	(1,678,122)
Debt extinguishment expense-related parties	(69,808)	(191,490)	(170,384)	(265,044)	(1,831,651)
Net loss	$ (573,589)	$ (1,437,304)	$ (1,065,433)	$ (1,844,982)	$ (39,987,047)
Net loss per common share
Basic and diluted (in dollars per share)	$ (0.03)	$ (0.08)	$ (0.06)	$ (0.11)	$ (7.34)
Weighted average number of shares outstanding:
Basic and diluted (in shares)	18,385,098	17,284,047	18,343,953	16,891,453	5,444,570